021-5137-0935
sales@aqbiopharma.com.cn
Yangzhou Fluorine Pharmaceutical Technology Co., Ltd. was founded in 2011 by a second prize winner of the National Natural Science Award, a team of innovative talents from Jiangsu Province, and multiple overseas returnee doctoral teams. It is a leading fluorine containing pharmaceutical technology company in China. The company focuses on the research and development of fluorinated pharmaceutical products and their process technologies, including fluorinated new drugs and intermediate products. Products and technologies are distributed in various stages of the pharmaceutical value chain: preclinical new drug development stage; Clinical stages I, II, and III; Research and development, preparation, sales, and technology transfer of rare heterocyclic structures and fluorinated new drug templates for products in the marketing stage. The main products that the company currently develops and matures are world advanced and leading products. In the research and development of fluorinated pharmaceutical products, we use our self-developed fluorinated block technology to replace fluorination technology, achieving industrialization of the products and enhancing our competitive position. At present, the company has multiple world-leading core patented technologies. The company's short-term and medium-term goal is to continue to develop world-class fluorinated pharmaceutical products and technologies, and expand market share. The long-term goal of the company is to develop non patented drugs based on fluorine atoms and new fluorinated drugs.
